Hussman Strategic Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Hussman Strategic Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$902.69 - $993.35 $1.9 Million - $2.09 Million	-2,100 Reduced 50.0%	2,100 $2.02 Million
Q3 2023 Nov 07, 2023	SELL	$692.45 - $844.37 $2.49 Million - $3.04 Million	-3,600 Reduced 46.15%	4,200 $3.46 Million
Q4 2022 Feb 08, 2023	SELL	$705.89 - $766.39 $1.06 Million - $1.15 Million	-1,500 Reduced 16.13%	7,800 $5.63 Million
Q3 2022 Nov 02, 2022	SELL	$573.97 - $724.32 $602,668 - $760,536	-1,050 Reduced 10.14%	9,300 $6.41 Million
Q2 2022 Sep 12, 2022	BUY	$548.35 - $738.84 $2.25 Million - $3.04 Million	4,110 Added 65.87%	10,350 $6.12 Million
Q1 2022 May 04, 2022	BUY	$595.12 - $698.43 $618,924 - $726,367	1,040 Added 20.0%	6,240 $4.36 Million
Q4 2021 Jan 31, 2022	BUY	$543.48 - $670.97 $2.83 Million - $3.49 Million	5,200 New	5,200 $3.28 Million
Q3 2020 Nov 02, 2020	SELL	$544.75 - $658.21 $2.23 Million - $2.7 Million	-4,100 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$336.18 - $494.43 $537,888 - $791,088	1,600 Added 64.0%	4,100 $2 Million
Q4 2019 Jan 31, 2020	SELL	$274.13 - $376.51 $685,325 - $941,275	-2,500 Reduced 50.0%	2,500 $939,000
Q2 2019 Jul 31, 2019	SELL	$299.6 - $414.82 $749,000 - $1.04 Million	-2,500 Reduced 33.33%	5,000 $1.57 Million
Q1 2019 May 01, 2019	BUY	$372.08 - $439.57 $2.79 Million - $3.3 Million	7,500 New	7,500 $3.08 Million

1,463

84.5M

907K

1.3M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.